Global In-vivo Imaging Market Research Report - Forecast till 2030

In Vivo (Preclinical) Imaging Market Research Report: By Application (Nuclear Imaging, Optical Imaging), By Techniques (Radioisotopes, Biomarkers, And Luminescent Proteins Based), And By End Users (Hospitals & Clinics, Imaging Centers, Research Organizations)- Global Forecast Till 2030

ID: MRFR/MED/0296-HCR | 115 Pages | Published By Rahul Gotadki on March 2023         

Global Preclinical in vivo Imaging Market Synopsis The preclinical in vivo imaging market is expected to reach USD 3,850 Million by 2030 at 5.20% CAGR during the forecast period 2022-2030. In vivo imaging refers to the visualization of various life processes within an organism. On the basis of this visualization, any abnormality prevailing within the biological systems can diagnosed as the presence of disease. With the increasing global burden of diseases, the demand for effective diagnosis and real time monitoring of treatment’s efficiency during the therapeutic period also increasing. This lead to the development of the in-vivo imaging techniques that facilitates better monitoring and diagnosis at molecular levels. In-vivo imaging techniques involves various technologically advanced paradigms that are used in diagnosis of various types of diseases such as cancer etc. In vivo imaging involves studying the cells’ interaction with the radioisotopes, biomarkers, luminescent proteins, or irradiations with electromagnetic radiations. On the basis of these interactions, the diagnosis and the treatment evaluation is done. Various techniques of in-vivo imaging includes techniques from PET (Positron Emission Tomography) to Diffuse Optical Tomography (DOT).

As per WHO report published in 2017, about 1 in 6 deaths occurred due to cancer in 2015, which made it the second leading cause of the deaths across the globe. Additionally, various types of cancer across the world caused about 8.8 million deaths in 2015, which boosted the market. Moreover, a report by the National Cancer Institute published in 2016 states that about 1.6 million new cases of cancer were diagnosed in 2010 and the national expenditures for cancer expected to reach USD 156 billion by 2020 from USD 125 billion in 2010. Therefore based on these facts, it can be calculated that the market for in-vivo imaging will expand along with the increasing demands for diagnosis and research on cancer. This will enable the U.S. to lead the market. Key Players in the Global In vivo Imaging Market Some of the key players profiled in the report are Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.

Intended Audience

  • Hospitals and clinics

  • Imaging Centers

  • In-vivo imaging systems manufacturers and suppliers

  • Academic institutes and universities

  • Research and development (R&D) companies

  • Healthcare service providers

Rising healthcare expenditures and increasing prevalence of cancer followed by R&D in the imaging technology for the diagnosis of various types of diseases such as cancer are the major drivers of the market growth. However, factors such as lack of awareness, uneven distribution of medical services over the regional boundaries, and low healthcare expenditures in developing countries may hamper the market growth over the assessment period.

Research Methodology In Vivo Imaging Market Preclinical In vivo Imaging Market Segments The global in vivo imaging market has been segmented on the basis of applications, techniques, and end users.

Based on the applications, the market has been segmented into nuclear imaging, optical imaging, and others.

Based on the techniques, the market has been segmented as radioisotopes based, biomarkers based, luminescent proteins based technique, and others.

Based on the end users, the market has been segmented as hospitals & clinics, imaging centers, research organizations, and others.

Preclinical In vivo Imaging Market Regional Analysis The Americas holds the largest market share owing to increasing prevalence of cancer, the presence of developed countries such as the U.S. and Canada in the region.

Europe holds the second largest market share. Factors such as increasing healthcare expenditures, rapid advancements in the healthcare services and technology will boost the market.

Asia Pacific market is expected to grow rapidly due to the presence of developing economies such as India and China, which are adopting new technologies in the medical service sector.

The Middle East & Africa will show the least growth owing the region’s low penetrance in the market. Factors such as lack of awareness and low per capita income will restrain the market in Africa. The market will be lead by the countries like Saudi Arabia in the Middle East. Figure 1    Global Preclinical In-vivo imaging market, by region, 2016 (% market share) Global In Vivo Imaging Market

The report for the global in vivo imaging market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The outlook of the global in-vivo imaging market looks like a continually growing space.

The valuation of global in-vivo imaging market is expected to reach approximately USD 3,850 Million by the end of 2030.

Rising demand for advanced imaging techniques for diagnosis of various chronic diseases such as cancer.

North America holds the largest share in the global in-vivo imaging market followed by Europe and Asia Pacific, respectively.

Bruker (US), MILabs B.V. (the Netherlands), FUJIFILM VisualSonics Inc. (Canada), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Aspect Imaging (Israel), TRIFOIL IMAGING (US), MR Solutions (UK), Biospace Lab S.A. (France), and New England Biolab (US), are some of the major players operating in the in-vivo imaging market.